Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
暂无分享,去创建一个
Wei Wu | Steven J. M. Jones | Shaun D. Jackman | Inanc Birol | Stephen Yip | Jenny Q. Qian | Richard Varhol | Yongjun Zhao | Martin Hirst | Eric Chuah | Annie Moradian | Readman Chiu | Sean Young | David N Louis | Nina Thiessen | Steven J M Jones | Gregg B Morin | Andrew J Mungall | Marco A Marra | Olena Morozova | Yaron S Butterfield | Samuel Weiss | Alexandra Maslova | I. Birol | S. Weiss | D. Louis | M. Marra | M. Hirst | Yongjun Zhao | R. Varhol | N. Thiessen | J. Cairncross | Y. Butterfield | G. Morin | A. Mungall | K. Mungall | R. Corbett | Readman Chiu | Jessica Tamura-Wells | Marlo Firme | S. Chittaranjan | S. Yip | Eric Chuah | A. Karsan | Haiyan I. Li | Wei Wu | O. Morozova | Jianghong An | M. Blough | C. Chesnelong | R. Docking | Alexandra Maslova | Richard D. Moore | A. Moradian | Marco Perizzolo | G. Roldan | E. Smith | Jessica Tamura-Wells | S. Young | J. Chan | Jennifer A Chan | Aly Karsan | Suganthi Chittaranjan | Karen L Mungall | J Gregory Cairncross | Marlo Firme | Richard Corbett | Richard Moore | Jianghong An | Jenny Qian | Michael D Blough | Charles Chesnelong | Rod Docking | Shaun Jackman | Haiyan Li | Marco Perizzolo | Gloria Roldan | Eric E Smith | Jessica Tamura-Wells | E. Smith | E. Chuah | Jennifer A Chan | H. Li | S. Jackman | Jennifer A. Chan | M. Firme | Jennifer A. Chan | Steven J. M. Jones | G. Roldán
[1] Jean-Yves Delattre,et al. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile , 2008, Molecular Cancer.
[2] Joel H. Saltz,et al. The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas , 2010, PloS one.
[3] K. Aldape,et al. International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. , 2011, Neuro-oncology.
[4] H. Aburatani,et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. , 2006, Human molecular genetics.
[5] Wai-In Chan,et al. CIC, a member of a novel subfamily of the HMG-box superfamily, is transiently expressed in developing granule neurons. , 2002, Brain research. Molecular brain research.
[6] Wai-In Chan,et al. CIC, a gene involved in cerebellar development and ErbB signaling, is significantly expressed in medulloblastomas , 2005, Journal of Neuro-Oncology.
[7] Steven J. M. Jones,et al. Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.
[8] N. Probst-Hensch,et al. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas , 2004, Acta Neuropathologica.
[9] S. Weiss,et al. Oligodendroglioma cell lines containing t(1;19)(q10;p10). , 2010, Neuro-oncology.
[10] Steven J. M. Jones,et al. Using next‐generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities , 2011, The Journal of pathology.
[11] Amar Gajjar,et al. Radial glia cells are candidate stem cells of ependymoma. , 2005, Cancer cell.
[12] Steven J. M. Jones,et al. Abyss: a Parallel Assembler for Short Read Sequence Data Material Supplemental Open Access , 2022 .
[13] S. Davis,et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.
[14] G. Reifenberger,et al. Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors , 2007, PloS one.
[15] Janghoo Lim,et al. ATAXIN-1 Interacts with the Repressor Capicua in Its Native Complex to Cause SCA1 Neuropathology , 2006, Cell.
[16] Barry Merriman,et al. U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line , 2010, PLoS genetics.
[17] Pieter Wesseling,et al. IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group , 2010, Clinical Cancer Research.
[18] Ryan D. Morin,et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. , 2009, The New England journal of medicine.
[19] Stephen Yip,et al. MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance , 2009, Clinical Cancer Research.
[20] Vladimir N Uversky,et al. Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma , 2010, Clinical Cancer Research.
[21] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[22] D J Goff,et al. Establishment of dorsal-ventral polarity of the Drosophila egg requires capicua action in ovarian follicle cells. , 2001, Development.
[23] M. Shago,et al. Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. , 2009, Cancer genetics and cytogenetics.
[24] Caterina Giannini,et al. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors , 2005, Cancer.
[25] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[26] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[27] S. Kesari,et al. Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. , 2010, Genes & cancer.
[28] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[29] B. Scheithauer,et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.
[30] Ryan D. Morin,et al. Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin , 2010, Nature Genetics.
[31] G. Jiménez,et al. Relief of gene repression by torso RTK signaling: role of capicua in Drosophila terminal and dorsoventral patterning. , 2000, Genes & development.
[32] Jianjie Ma,et al. Ataxin‐1 and Brother of ataxin‐1 are components of the Notch signalling pathway , 2011, EMBO reports.
[33] C. Brennan,et al. Molecular subclassification of diffuse gliomas: Seeing order in the chaos , 2011, Glia.
[34] S. Pulst,et al. dAtaxin-2 Mediates Expanded Ataxin-1-Induced Neurodegeneration in a Drosophila Model of SCA1 , 2007, PLoS genetics.
[35] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[36] Yuchen Jiao,et al. Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma , 2011, Science.
[37] C. Hoogenraad,et al. Segregation of non‐p.R132H mutations in IDH1 in distinct molecular subtypes of glioma , 2010, Human mutation.
[38] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[39] D. Louis,et al. Chemosensitive gliomas in adults: which ones and why? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[41] K. Hoang-Xuan,et al. NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas , 2009, PloS one.
[42] Kevin P. Murphy,et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors , 2010, Bioinform..
[43] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[44] Steven J. M. Jones,et al. De novo assembly and analysis of RNA-seq data , 2010, Nature Methods.
[45] Steven J. M. Jones,et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers , 2011, Nature.
[46] F. Dasí,et al. Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression , 2009, Journal of Neuro-Oncology.
[47] M. Nikiforova,et al. Diagnostic Use of IDH1/2 Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues , 2009, Journal of neuropathology and experimental neurology.
[48] Andrew P. Stubbs,et al. Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas , 2011, PloS one.
[49] R. Barnard,et al. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.
[50] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[51] Inanç Birol,et al. Human variation database: an open-source database template for genomic discovery , 2011, Bioinform..
[52] I. Hariharan,et al. Capicua Regulates Cell Proliferation Downstream of the Receptor Tyrosine Kinase/Ras Signaling Pathway , 2007, Current Biology.
[53] Richard A. Moore,et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.
[54] Tracy T Batchelor,et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. , 2006, Cancer research.